Expression of CCN1 has been shown to correlate with tumor progression and poor patient prognosis in glioma patients (Xie et al., 2004a) and to enhance tumorigenicity of glioma cells (Xie et al., 2004b). The gene discussed is CCN1; the disease is glioma.